PSMA-11 without HBED chelator is an unchelated form of the PSMA-binding peptide used to examine receptor affinity independent of metal coordination. Removal of HBED alters polarity and steric properties, highlighting peptide-only contributions to binding. Researchers analyze its conformation and interaction kinetics. Applications include PSMA-ligand design, peptide-only binding studies, and structure-activity evaluation.
CAT No: R2755
PSMA-11 without HBED chelator is a specialized carbohydrate-based compound designed for advanced research applications in the field of molecular imaging and targeted ligand development. Unlike the conventional PSMA-11, which is typically conjugated with the HBED-CC chelator for radiometal labeling, this variant is provided in its unconjugated form, offering researchers greater flexibility in customizing chelation strategies or further chemical modifications. The molecule retains its high affinity for the prostate-specific membrane antigen (PSMA), a well-characterized cell surface protein overexpressed in certain cancer cells, making it a valuable tool for developing novel targeting agents. By omitting the HBED chelator, this form allows for site-specific attachment of alternative chelators or functional groups, enabling the creation of bespoke conjugates tailored to unique experimental needs. Its robust carbohydrate scaffold ensures stability and compatibility with a range of synthetic and analytical techniques, supporting innovative research in bioconjugation and ligand engineering.
Targeted Ligand Development: PSMA-11 without HBED chelator serves as an essential intermediate for researchers aiming to design and synthesize custom PSMA-targeted ligands. The absence of a pre-attached chelator allows scientists to introduce alternative chelating moieties, fluorescent labels, or other functional groups at precise positions on the molecule. This flexibility is particularly advantageous when optimizing pharmacokinetics, biodistribution, or imaging properties for preclinical studies. By starting with the unconjugated form, researchers can systematically evaluate the impact of different modifications on binding affinity and selectivity, accelerating the development of next-generation molecular probes for PSMA-expressing tissues.
Radiopharmaceutical Research: In the context of radiopharmaceutical development, the unconjugated PSMA-11 backbone provides a versatile platform for exploring novel radiometal-chelator systems. Scientists can attach a variety of chelators, such as DOTA, NOTA, or others, to facilitate labeling with a broad spectrum of radioisotopes. This approach enables the assessment of radiolabeled conjugates for stability, in vivo targeting efficiency, and imaging contrast, supporting the identification of optimal candidate molecules for further translational research. The ability to fine-tune the chelation chemistry is crucial for adapting to different imaging modalities and improving the performance of PSMA-targeted radiotracers.
Bioconjugation Methodology Development: The availability of PSMA-11 without HBED chelator is particularly valuable for researchers focused on developing and validating new bioconjugation techniques. Its reactive functional groups can be exploited for site-specific attachment to various biomolecules, nanoparticles, or polymers, facilitating the creation of multifunctional conjugates. These customized constructs can be employed in diverse applications, such as targeted drug delivery, in vitro diagnostics, or bioanalytical assays. The unconjugated form allows for direct comparison of different conjugation strategies, enabling the optimization of reaction conditions, linker stability, and overall construct performance.
Structure-Activity Relationship Studies: For scientists investigating the structure-activity relationships (SAR) of PSMA-targeted ligands, the unconjugated carbohydrate scaffold offers a blank canvas for systematic modification. By introducing structural variations at specific sites, researchers can probe the effects of different substituents on binding affinity, selectivity, and biological activity. This iterative approach provides valuable insights into the molecular determinants of PSMA recognition and paves the way for the rational design of improved ligands. The modular nature of the product supports high-throughput synthesis and screening, accelerating the discovery of optimized targeting agents.
Chemical Biology Tool Development: PSMA-11 without HBED chelator also finds application in the creation of chemical biology tools for mechanistic studies of PSMA function and localization. By incorporating photoaffinity labels, crosslinkers, or other bioorthogonal handles, researchers can generate specialized probes for use in cell-based assays, pull-down experiments, or imaging studies. These tools enable detailed investigation of PSMA-mediated pathways, protein-protein interactions, and cellular trafficking, contributing to a deeper understanding of PSMA biology and its role in disease. The unconjugated form's adaptability ensures compatibility with a wide range of chemical modifications and experimental approaches, making it a valuable resource for chemical biology research.
1. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
5. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.